Lv31
360 积分 2024-04-12 加入
Design and development of an efficient convergent synthetic strategy for novel β-lactam enhancer zidebactam (WCK 5107)
3小时前
已完结
Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728
4小时前
已完结
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
3天前
已完结
吸入用抗生素在呼吸系统疾病中的应用研究进展
7天前
已完结
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics
12天前
已完结
Cefepime-Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
17天前
已完结
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials
20天前
已完结
Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery
24天前
已完结
皖公网安备34019202002308
